Title of article
Patients’ knowledge and perspectives on vitamin K antagonists for stroke prevention in atrial fibrillation: implications for treatment quality
Author/Authors
Polovina, Marija Clinic of Cardiology - Clinical Center of Serbia - and School of Medicine - Belgrade University - Belgrade - Serbia , Djikic, Dijana Clinic of Cardiology - Clinical Center of Serbia - Belgrade - Serbia , Vlajkovic, Ana School of Medicine - Belgrade University - Belgrade - Serbia , Vilotijevic, Matej School of Medicine - Belgrade University - Belgrade - Serbia
Pages
2
From page
239
To page
240
Abstract
Contemporary management of atrial fibrillation (AF) focuses
on effective thromboprophylaxis with either direct oral anticoagulants (DOACs) or vitamin K antagonists (VKAs; e.g., warfarin/
acenocoumarol). Although DOACs offer a viable alternative, the
majority of patients continue to receive VKAs. The quality of VKA
therapy is determined by the proportion of time spent in the target range (TTR) of the international normalized ratio (INR, 2.0–
3.0). The greatest benefit with VKAs is derived with TTR of ≥70%
(1), whereas a low TTR predisposes to adverse outcomes (2)
Keywords
Patients’ knowledge , perspectives , vitamin K antagonists , stroke prevention , atrial fibrillation , implications , treatment quality
Journal title
The Anatolian Journal of Cardiology: Andolu Kardiyoloji Dergisi
Serial Year
2017
Record number
2618084
Link To Document